Investing.com -- TuHURA Biosciences Inc (NASDAQ:HURA) stock gained 2.8% premarket Monday after the company announced its research on the Delta Opioid Receptor (DOR) in cancer immunotherapy was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback